202 related articles for article (PubMed ID: 21269271)
1. WT1 and its transcriptional cofactor BASP1 redirect the differentiation pathway of an established blood cell line.
Goodfellow SJ; Rebello MR; Toska E; Zeef LA; Rudd SG; Medler KF; Roberts SG
Biochem J; 2011 Apr; 435(1):113-25. PubMed ID: 21269271
[TBL] [Abstract][Full Text] [Related]
2. Repression of transcription by WT1-BASP1 requires the myristoylation of BASP1 and the PIP2-dependent recruitment of histone deacetylase.
Toska E; Campbell HA; Shandilya J; Goodfellow SJ; Shore P; Medler KF; Roberts SG
Cell Rep; 2012 Sep; 2(3):462-9. PubMed ID: 22939983
[TBL] [Abstract][Full Text] [Related]
3. Prohibitin is required for transcriptional repression by the WT1-BASP1 complex.
Toska E; Shandilya J; Goodfellow SJ; Medler KF; Roberts SG
Oncogene; 2014 Oct; 33(43):5100-8. PubMed ID: 24166496
[TBL] [Abstract][Full Text] [Related]
4. Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation.
Green LM; Wagner KJ; Campbell HA; Addison K; Roberts SG
Nucleic Acids Res; 2009 Feb; 37(2):431-40. PubMed ID: 19050011
[TBL] [Abstract][Full Text] [Related]
5. BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1.
Carpenter B; Hill KJ; Charalambous M; Wagner KJ; Lahiri D; James DI; Andersen JS; Schumacher V; Royer-Pokora B; Mann M; Ward A; Roberts SG
Mol Cell Biol; 2004 Jan; 24(2):537-49. PubMed ID: 14701728
[TBL] [Abstract][Full Text] [Related]
6. WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1.
Belali T; Wodi C; Clark B; Cheung MK; Craig TJ; Wheway G; Wagner N; Wagner KD; Roberts S; Porazinski S; Ladomery M
Biochim Biophys Acta Gene Regul Mech; 2020 Dec; 1863(12):194642. PubMed ID: 33017668
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol is required for transcriptional repression by BASP1.
Loats AE; Carrera S; Fleming AF; Roberts ARE; Sherrard A; Toska E; Moorhouse AJ; Medler KF; Roberts SGE
Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34266955
[TBL] [Abstract][Full Text] [Related]
8. WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene.
Montano G; Vidovic K; Palladino C; Cesaro E; Sodaro G; Quintarelli C; De Angelis B; Errichiello S; Pane F; Izzo P; Grosso M; Gullberg U; Costanzo P
Oncotarget; 2015 Sep; 6(29):28223-37. PubMed ID: 26320177
[TBL] [Abstract][Full Text] [Related]
9. Podocyte apoptosis in diabetic nephropathy by BASP1 activation of the p53 pathway via WT1.
Zhang Y; Xu C; Ye Q; Tong L; Jiang H; Zhu X; Huang L; Lin W; Fu H; Wang J; Persson PB; Lai EY; Mao J
Acta Physiol (Oxf); 2021 May; 232(1):e13634. PubMed ID: 33615732
[TBL] [Abstract][Full Text] [Related]
10. The WT1-BASP1 complex is required to maintain the differentiated state of taste receptor cells.
Gao Y; Dutta Banik D; Muna MM; Roberts SG; Medler KF
Life Sci Alliance; 2019 Jun; 2(3):. PubMed ID: 31167803
[TBL] [Abstract][Full Text] [Related]
11. Role of WT1-ZNF224 interaction in the expression of apoptosis-regulating genes.
Montano G; Cesaro E; Fattore L; Vidovic K; Palladino C; Crescitelli R; Izzo P; Turco MC; Costanzo P
Hum Mol Genet; 2013 May; 22(9):1771-82. PubMed ID: 23362234
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation by the Wilms' tumour suppressor protein WT1.
Wagner KJ; Roberts SG
Biochem Soc Trans; 2004 Dec; 32(Pt 6):932-5. PubMed ID: 15506928
[TBL] [Abstract][Full Text] [Related]
13. Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance.
Dong L; Pietsch S; Tan Z; Perner B; Sierig R; Kruspe D; Groth M; Witzgall R; Gröne HJ; Platzer M; Englert C
J Am Soc Nephrol; 2015 Sep; 26(9):2118-28. PubMed ID: 25556170
[TBL] [Abstract][Full Text] [Related]
14. Characterization of BASP1-mediated neurite outgrowth.
Korshunova I; Caroni P; Kolkova K; Berezin V; Bock E; Walmod PS
J Neurosci Res; 2008 Aug; 86(10):2201-13. PubMed ID: 18438920
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells.
Svensson E; Vidovic K; Lassen C; Richter J; Olofsson T; Fioretos T; Gullberg U
Leukemia; 2007 Dec; 21(12):2485-94. PubMed ID: 17728783
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
[TBL] [Abstract][Full Text] [Related]
17. Regulated expression of the alpha isoform of the human thromboxane A2 receptor during megakaryocyte differentiation: a coordinated role for WT1, Egr1, and Sp1.
Gannon AM; Turner EC; Reid HM; Kinsella BT
J Mol Biol; 2009 Nov; 394(1):29-45. PubMed ID: 19747485
[TBL] [Abstract][Full Text] [Related]
18. WT1 regulates HOXB9 gene expression in a bidirectional way.
Schmidt V; Sieckmann T; Kirschner KM; Scholz H
Biochim Biophys Acta Gene Regul Mech; 2021; 1864(11-12):194764. PubMed ID: 34508900
[TBL] [Abstract][Full Text] [Related]
19. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
McCoy C; McGee SB; Cornwell MM
Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory mechanism of pure curcumin on Wilms' tumor 1 (WT1) gene expression through the PKCα signaling pathway in leukemic K562 cells.
Semsri S; Krig SR; Kotelawala L; Sweeney CA; Anuchapreeda S
FEBS Lett; 2011 Jul; 585(14):2235-42. PubMed ID: 21658388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
